STOCK TITAN
  1. Home
  2. PAND

Pandion Therapeutics Stock Price, News & Analysis

PAND NASDAQ

Company Description

Pandion Therapeutics (NASDAQ: PAND) is a publicly traded research and development in biotechnology company in the Professional, Scientific, and Technical Services sector.

PAND stock has gained 231.8% over the past year.

This page provides a comprehensive overview of PAND stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
+231.77%
Performance 1 year
$0.0
Market Cap
28.0M
Shares outstanding

Pandion Therapeutics (PAND) stock. Over the past 12 months, the stock has gained 231.8%.

Latest News

View All
+133.36%

Merck to Acquire Pandion Therapeutics

acquisition
+9.36%

Pandion Therapeutics Presents Preclinical Data Highlighting Potential of Tissue-Tethered PD-1 Agonist to Locally Target Autoimmune Disease at the nPOD 13th Annual Scientific Meeting

clinical trial
-1.50%

Pandion Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference

conferences
+47.74%

Pandion Therapeutics Announces Positive Top-Line Phase 1a Clinical Data Showing PT101 was Well-Tolerated and Selectively Expanded Regulatory T cells

clinical trial
-0.35%

Pandion Therapeutics Appoints Katina Dorton to its Board of Directors

management
+11.43%

Pandion Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update

earnings

Pandion Therapeutics has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include acquisition, clinical trial, conferences, management, earnings. View all PAND news →

SEC Filings

View All

No SEC filings available for PAND.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

PAND Company Profile & Sector Positioning

Pandion Therapeutics (PAND) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the NASDAQ.